Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Maternally expressed gene 8 (MEG8) is a long non-coding RNA (lncRNA) encoded within the DLK1-DIO3 imprinted locus. MEG8 does not code for a protein but regulates gene expression through multiple epigenetic and post-transcriptional mechanisms. It is known to associate with the chromatin-modifying enzyme EZH2, recruiting it to specific genomic loci to drive H3K27 methylation and transcriptional repression. MEG8 is critical for modulating epithelial-mesenchymal transition (EMT) in certain cancers, acting in concert with other lncRNAs, such as MEG3, to regulate genes involved in cell adhesion, migration, and invasion[1]. Furthermore, MEG8 functions in the immune system by acting as a competitive endogenous RNA (ceRNA), sponging microRNA-107 and regulating the expression of STAT3, a transcription factor important for the differentiation of T regulatory cells (Treg) and Th17 cells[2]. Its dysregulation has been implicated in cancer progression and in immune-related diseases characterized by T cell imbalance. MEG8 is not a direct therapeutic target (receptor, enzyme, transporter), but rather a regulatory RNA with emerging significance in epigenetics, cancer biology, and immunology[1][2].
Associates with EZH2 (a component of Polycomb Repressive Complex 2) to induce H3K27 methylation and silence specific genes; Functions as a sponge for microRNA-107, thereby modulating STAT3 levels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Maternally expressed gene 8 long non-coding RNA (MEG8).